Background & Objective: Bone tissue is one of the principal tissues in the human body and its transplantation has always been performed. Autogeneic and allogeneic grafts have their limitations including rejection, prolonged surgery time, infections, and possible mortality and also difficulty for repreparation of allograft. For this reason, biomaterials with osteoinductive and osteoconductive properties are quantitatively and qualitatively more appropriate for bone defects. Human endochondral bone matrix gelatin (HECBMG) with a stronger osteoinductive property as compared to other biomaterials and with physical and chemical similariteis to natural bone composition and less stimulation of inflammatory response in host tissue are new and suitable candidates for this purpose. Considering the significance of bone defect repair and stimulation of undifferentiated mesenchymal cells, the goal of this research was to evaluate the cytotoxicity of this biomaterial.Materials & Methods: After preparation and sterilization of HECBMG, the screening of our product for pathogenic agents including microbes, yeast and bacteria was done in blood agar medium. Then, it is divided into 10, 20, 50 mg portions and cultured on 24-well of 100000 mononuclear cells of peripheral blood and they are evaluated after 24, 48 and 72 hours. MTT method was used for evaluation of cytotoxic effect using ELISA reader. Light absorption rate depends on MTT uptake by the cells, indicating vital activity of the cells. The experiment was done 3 times for each of 3 concentrations and its average was reported. For statistical analysis, t test was used.Results: None of the doses that were used were toxic and all of them increased number of the human peripheral blood mononuclear cells.Conclusion: With increasing of HECBMG concentration and passing time, increasing of human peripheral blood mononuclear cells can be observed and it has a statistically significant difference with control group. Therefore, as a conclusion, HECBMG is compatible with human blood mononuclear cells.